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Introduction
Catheter ablation (CA) has become an accepted treatment 
option for recurrent, symptomatic, drug-resistant atrial fibrillation 
(AF). Isolating or encircling all accessible pulmonary veins (PVs) is 
identified as the cornerstone of any ablation approach. The number 
of operators and hospitals performing this procedure is increasing. 
Despite the satisfactory results justifying the introduction of CA 
in the international guidelines in selected patients also at an early 
AF management stage, safety of this procedure remains cause for 
concern.1,2 Complication rate range from 3.5% to 6.0%,3-10 but few 
data are present in Literature regarding the influence of age on 
incidence of complications.11-14 Females are considered at higher 
risk of complications in all percutaneous procedures.15,16 Recently an 
higher risk of complications has been reported in female undergoing 
AF catheter ablation too.7-10,17 Aim of the present study was to 
assess the influence of age and gender on incidence and severity 
of complications of CA for AF in an contemporary, unselected 
population of consecutive patients.
Methods
Study Population
 Clinical and procedural data concerning consecutive patients who 
underwent CA for AF in 29 Italian electrophysiology laboratories 
between January 1 and December 31, 2011 were collected. 
This observational study was approved by the local institutional 
review committees, and written informed consent was obtained from 
each patient.
Ablation
 Details of anticoagulation strategy and ablation protocols have 
already been reported.8 Briefly, all ablation strategies aiming at 
isolating or encircling the PVs (radiofrequency ablation, circular 
multielectrode ablation, cryoablation) were included in the Registry. 
Additional linear lesions in the right or left atrium were also allowed.
Definitions
 Major complications included all events that resulted in death or 
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Abstract
Background:  Despite catheter ablation (CA) has become an accepted treatment option for symptomatic, drug-resistant atrial fibrillation 
(AF), safety of this procedure continues to be cause for concern.
Objective:  Aim of the present multicenter study was to assess the influence of age and gender on incidence and severity of early CA 
complications.
Methods: From January 1, 2011 to December 31, 2011, data from 2,323 consecutive patients who underwent CA (mean age 59.1+10.9; 
72.3% male) for AF in 29 Italian centres were collected. All complications occurring to the patients from admission to 30th post-procedural 
day were recorded.
Results: Complications occurred in 94 patients (4.0%); of these 7 (0.30%) developed permanent sequelae. There was a significant trend 
toward a greater incidence of complications with increasing age-group. In particular, the incidence of complications was 35/1066 (3.3%) 
in patients < 60 year-old vs 59/1257 (4.7%) in those > 60 year-old (p=0.03). All 7 patients with permanent sequeale were older than 60. 
Females had a higher incidence of complications both among younger [13/231 (5.6%) vs 22/915 (2.5%), p=0.02] and older patients 
[32/405 (7.9%) vs 27/739 (3.5%) p=0.001]. In subjects older than 60, 5/405 (1.2%) females and 2/176 (0.3%) males (p=0.04) suffered 
from permanent sequelae. 
Conclusions: Older patients and females are a subgroup at higher risk of complications during AF ablation. A particular care should be 
taken when performing CA in this clinical setting. 
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permanent injury, prolonged or required intervention for treatment, 
or required or prolonged hospital stay beyond the scheduled period. 
Early tachyarrhythmias (AF or atrial tachycardia/flutter) were not 
included even if they required cardioversion to be terminated.18
Permanent sequelae included all events that resulted in death or 
permanent injury.
Vascular complications included: femoral hematoma, arteriovenous 
fistula, femoral pseudoaneurysm, and subclavian hematoma.
Hemodynamic complications included: PV stenosis, cardiac 
tamponade, pericarditis, and hemothorax.
Ischaemic complications included: ischemic stroke, transient 
ischemic attack, and acute myocardial infarction.
Data Collection
 The investigators were provided with the same data sheet for the 
collection of specific information on each ablation procedure. Data 
were gathered retrospectively by each investigator, and sent via a 
computerized database in Excel format (Windows 7, XP, or Mac) to 
the coordinating centre for analysis. Each author took responsibility 
for data integrity.
Statistical Analysis
 Normally distributed continuous variables were expressed as mean 
(SD) and compared with the Student’s T-Test. Skewed variables 
were expressed as median (25-75 %iles) and compared with the 
runk-sum test. Normality was assessed using the Shapiro-Wilk test. 
Categorical variables were presented as counts and percentages, and 
compared with chi-squared or Fisher’s exact test, as appropriate. The 
Linear by Linear Association test was used to test for a linear trend 
in proportions of complications across age groups.
At multivariate analysis, a logistic regression model was designed 
and stepwise backward selection was performed in order to identify 
significant and independent predictors of complications. The starting 
model included: gender; age (< or > 59 years); left ventricular 
ejection fraction (< or > 57%); and mean procedural duration (< or 
> 147 minutes). The mean value was used as cut-off to categorize 
continuous variables (age, left ventricular ejection fraction, and mean 
procedural duration). A significant increase in risk was obtained if 
the 95% confidence interval exceeded 1 and the p value of the Wald 
test was <0.05. 
Analysis was performed by means of SPSS (version 11.0, SPSS 
Inc., Chicago, Illinois, USA).
Results
Clinical And Procedural Data
 The final patient cohort included 2,323 consecutive patients 
[median age 60 (52-67) years; 72.3% male]. Distribution of age and 
gender among the study population is shown in Figure 1. 
An open irrigated-tip catheter was used in 2,169 cases (93.4%), 
while a cryo-balloon catheter and a circular multielectrode catheter 
were used in 97 (4.2%) and 57 patients (2.5%), respectively.
Major Complications
 No procedure-related death was observed. Major complications 
occurred in 94 patients (4.0%) (Table 1). Seven (0.30%) of these 
patients developed permanent sequelae: 3 ischemic stroke (0.13%); 2 
phrenic nerve paralysis (0.09%); 1 hemorragic stroke (0.04%); and 1 
myocardial infarction (0.04%).
Influence of Age on Complications
 There was a significant trend toward a greater incidence of 
complications with increasing age-group (Figure 2). In particular, the 
incidence of complications was 35/1066 (3.3%) in patients < 60 year-
old vs 59/1257 (4.7%) in those > 60 year-old (p=0.03). All 7 patients 
with permanent sequelae were older than 60.
Table 1: Major complications occurred in the 2,323 enrolled patients
Complication Patients 
Vascular access complications 50 (2.2%)
Femoral hematoma 28
Arteriovenous fistula 13
Femoral pseudoaneurysm 7
Subclavian hematomas 2
Cardiac tamponade 12 (0.5%)
Pericarditis 14 (0.6%)
Transient ischemic attack 5 (0.2%)
Stroke 4 (0.15%)
Ischemic 3
Hemorragic 1
Phrenic nerve paralysis 3 (0.1%)
Hemothorax 3 (0.1%)
Others 3 (0.1%)
Figure 1:
Distribution of age and gender among the study population. 
Males=black bar; females=grey bar. Absolute numbers are 
presented at the top of the bar
Figure 2: Distribution of complications among age groups. Major 
complications=grey bar; permanent sequela=black bar
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Influence of Gender on Complications
 Complications occurred more frequently in females than in males 
[44/522 (8.4%) vs 50/1801 (2.8%), p=0.001]. Females had a higher 
incidence of complications both among younger (< 60 years) [13/208 
(6.3%) vs 21/858 (2.4%), p=0.01] and older (> 60 years) patients 
[31/414 (7.5%) vs 29/843 (3.4%) p=0.01]. In subjects older than 60, 
6/414 (1.45%) females and 1/843 (0.12%) males (p=0.02) suffered 
from permanent sequelae (Figure 3).     
All types of complications (hemodynamic, vascular, and ischaemic) 
resulted significantly more frequent in females than in males (Figure 
4).
At multivariate analysis, female gender (OR 2.643, 95% CI 1.686 
to 4.143,  p<0.0001) and longer procedural duration (OR 2.195, 95% 
CI 1.388-3.473, p<0.001) independently predicted a higher risk of 
procedural complications.
Discussion
Main Findings
 In this large multicenter National study a greater incidence of 
complications after CA for AF was documented with increasing 
age. Permanent sequelae occurred only in older patients. Females 
presented a higher incidence of complications than males throughout 
all age-groups. All types of complications (hemodynamic, vascular, 
and ischaemic) resulted significantly more frequent in females than 
in males.
Influence of Age on Complications
 Radiofrequency CA has emerged as an important treatment option 
for refractory AF. The incidence of AF is higher in the elderly,19 
but this cohort of patients is usually underrepresented in clinical 
studies assessing the efficacy and safety of AF ablations. . Moreover, 
elderly patients with AF undergoing CA are often female with a 
higher incidence of structural heart disease and/or hypertension. 
Randomized trials20-22 have included few elderly patients, and the 
safety and efficacy of AF ablation was not adequately assessed in 
this subset. These limitations drove early guidelines for catheter 
ablation of AF to suggest a more conservative approach in the 
elderly. Recently, several Authors11-14,23 reported data on AF ablation 
in patients ≥ 66 years demonstrating that AF catheter ablation is 
safe and efficacious in older patients too. Thus, older age is not more 
considered a contraindication to AF CA in the recent guidelines.1,2 
Nevertheless, some concerns remain about the AF catheter ablation 
safety in the elderly. In several registries older age has been reported 
as a predictor of complication in AF catheter ablation. Shah et al7 
among 4.156 patients who underwent an initial AF ablation, found 
a 5% of periprocedural complications. Older age, female sex, prior 
AF hospitalizations, and recent hospital procedure experience 
were associated with a higher risk of complications and/or 30-day 
readmission after AF ablation. Deshmukh et al9 reported data on 
93801 patients with AF treated with catheter ablation from the 
Nationwide Inpatient Sample data set from 2000 to 2010. Catheter 
ablation of AF in older patients (age >80) was associated with a 
higher total complication rate (9.37 %) in comparison with younger 
patients (age <80, p<0.001). The results of our study confirms these 
findings showing a significant trend toward a greater incidence of 
complications with increasing age-group . Of note all 7 patients with 
permanent sequelae were older than 60. Although these data arise 
some concerns about the AF ablation in the elderly they seem to 
further support the safety of AF catheter ablation when used as first 
line therapy in younger patients. The lack of severe complications in 
these subgroup seems to confirms the data of Leong-Sit P et al24 
which demonstrated that in patients younger than 45 years, there is a 
lower major complication rate and a comparable efficacy rate, with a 
greater chance of being AF free without antiarrhythmic drugs.
Influence of Gender on Complications
 Although women are undergoing fewer AF ablations procedures 
than men, female gender has been identified as a predictor of 
complications of AF ablation in several studies.7-10,17 Our results 
confirmed this finding.
The increased procedural risk for women undergoing AF 
ablation was consistent with a more than 2-fold higher risk of 
vascular complications than men15,16 during percutaneous coronary 
intervention. Smaller body size and vessels and higher levels of 
anticoagulation among women have been suggested7 as a possible 
explanation for the high percentage of vascular complication. The 
smaller body size of women carries also a smaller heart size. Smaller 
chamber size in women may theoretically restrict the manipulation 
of catheter, which leads to the lower success rate in women25 and 
could increase the catheter manipulation related complications. Of 
note in our study. 
female gender predict not only vascular complication but every 
kind of complications.
Figure 4: Incidence of different types of major complications according to 
gender. Males=black bar; females=grey bar
Figure 3:
Incidence of major complications according to gender among age 
groups. Major complications=grey bar; permanent sequela=black 
bar
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